Oral administration of probiotic Lactobacillus casei Shirota relieves pain after single rib fracture: a randomized double-blind, placebo-controlled clinical trial.

2018-01-01
Asia Pacific journal of clinical nutrition 27(6)
- Min Lei
- Chunhua Guo
- Yong Wang
- Limei Hua
- Sujuan Xue
- Dan Yu
- Chunhua Zhang
- Dawei Wang

PubMed: 30485924
DOI: 10.6133/apjcn.201811_27(6).0012

Study Design

Type: Randomized Controlled Trial (RCT)
Sample size: n = 283
Population: 283 eligible patients who had a single rib fracture
Methods: randomly assigned to receive skimmed milk containing either a commercial probiotic LcS or placebo every day through oral administration for 1 month after the fracture
Duration: 1 month
Funding: Unclear

Large Human Trial

Background and objectives

Probiotic treatment has proven to increase the density of bone mass, prevent against bone loss, and improve bone formation. We aimed to assess the effect of oral administration of the probiotic Lactobacillus casei Shirota (LcS) on pain relief in patients with single rib fracture.

Methods and study design

A total of 283 eligible patients who had a single rib fracture were enrolled and randomly assigned to receive skimmed milk containing either a commercial probiotic LcS or placebo every day through oral administration for 1 month after the fracture. The pain relief effect was assessed during activities that elicited pain; meanwhile, sleep quality and sustained maximal inspiration (SMI) lung volumes were monitored.

Results

Patients in the LcS group had more effective pain relief than those in the placebo group during deep breathing, coughing and turning over the body. Between the two groups of patients, increase in SMI lung volume was larger in LcS group patients than that of patients in the placebo group. Sleep quality did not show significant improvements after 1 month LcS treatment.

Conclusions

In patients with a single rib fracture, oral administration of the probiotic LcS could exhibit alleviating effects on pain intensity.

Research Insights

Lacticaseibacillus casei→Improved Sleep Quality
Sleep quality did not show significant improvements after 1 month LcS treatment.
Effect
Neutral
Effect size
Small
Lacticaseibacillus casei→Increased Sustained Maximal Inspiration Lung Volume
increase in SMI lung volume was larger in LcS group patients than that of patients in the placebo group.
Effect
Beneficial
Effect size
Small
Lacticaseibacillus casei→Reduced Pain During Coughing
Patients in the LcS group had more effective pain relief than those in the placebo group during deep breathing, coughing and turning over the body.
Effect
Beneficial
Effect size
Small
Lacticaseibacillus casei→Reduced Pain During Deep Breathing
Patients in the LcS group had more effective pain relief than those in the placebo group during deep breathing, coughing and turning over the body.
Effect
Beneficial
Effect size
Small
Lacticaseibacillus casei→Reduced Pain on Turning Over
Patients in the LcS group had more effective pain relief than those in the placebo group during deep breathing, coughing and turning over the body.
Effect
Beneficial
Effect size
Small